Stock comparison

MRKvsVTRS

Merck & Co IncvsViatris Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

MRK

Merck & Co Inc

$114.62

+15.57%

Pharmaceuticals$298.8BNYSE

VTRS

Viatris Inc

$14.75

+26.61%

Pharmaceuticals$15.6BNASDAQ

60-day price, rebased to 100

MRK +1.10% · VTRS +13.72%

Round-by-round

MRK 3·VTRS 2· 1tie

EdgeVTRS

Valuation upside

-26.90% vs +97.70% to DCF fair value

EdgeMRK

Balance-sheet strength

Altman Z 4.02 vs 0.89

Tie

Fundamental quality

Piotroski 4.00 vs 4.00 (of 9)

EdgeMRK

Growth + margins

Rule-of-40 20.30 vs 10.00

EdgeVTRS

60-day momentum

+1.10% vs +13.72% price return

EdgeMRK

Market-cap liquidity

$298.8B vs $15.6B

Verdict

Across6categories,MRKtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onMRKorVTRS

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.